Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,113 JPY | -0.92% | -0.48% | +1.46% |
05-16 | Takeda Canada Completes LOI Stage for Post-Transplant Cytomegalovirus Treatment | MT |
05-15 | Takeda Pharmaceutical's Dengue Vaccine Granted WHO Prequalification | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.46% | 41.5B | |
+39.22% | 727B | |
+30.57% | 592B | |
-7.85% | 347B | |
+15.48% | 319B | |
-0.12% | 274B | |
+12.55% | 238B | |
+6.65% | 204B | |
-6.09% | 203B | |
-3.37% | 160B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Transcript : Takeda Pharmaceutical Company Limited, Q4 2022 Earnings Call, May 11, 2022